These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36179018)

  • 21. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
    Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
    J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
    Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells.
    Shi LZ; Wang R; Huang G; Vogel P; Neale G; Green DR; Chi H
    J Exp Med; 2011 Jul; 208(7):1367-76. PubMed ID: 21708926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes.
    Natarajan C; Bright JJ
    J Immunol; 2002 Jun; 168(12):6506-13. PubMed ID: 12055272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis.
    Glenn JD; Smith MD; Calabresi PA; Whartenby KA
    Stem Cells; 2014 Oct; 32(10):2744-55. PubMed ID: 24911892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells.
    Kleinewietfeld M; Manzel A; Titze J; Kvakan H; Yosef N; Linker RA; Muller DN; Hafler DA
    Nature; 2013 Apr; 496(7446):518-22. PubMed ID: 23467095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE).
    Moore CS; Hebb AL; Blanchard MM; Crocker CE; Liston P; Korneluk RG; Robertson GS
    J Neuroimmunol; 2008 Oct; 203(1):79-93. PubMed ID: 18687476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity.
    Nath N; Khan M; Rattan R; Mangalam A; Makkar RS; de Meester C; Bertrand L; Singh I; Chen Y; Viollet B; Giri S
    Biochem Biophys Res Commun; 2009 Aug; 386(1):16-20. PubMed ID: 19486896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
    Cheng W; Zhao Q; Xi Y; Li C; Xu Y; Wang L; Niu X; Wang Z; Chen G
    Mol Immunol; 2015 Mar; 64(1):152-62. PubMed ID: 25433436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
    Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
    Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cardiac myocyte-restricted Lin28/let-7 regulatory axis promotes hypoxia-mediated apoptosis by inducing the AKT signaling suppressor PIK3IP1.
    Joshi S; Wei J; Bishopric NH
    Biochim Biophys Acta; 2016 Feb; 1862(2):240-51. PubMed ID: 26655604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Zinc Chelator, 1H10, Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating Zinc Toxicity and AMPK Activation.
    Choi BY; Jeong JH; Eom JW; Koh JY; Kim YH; Suh SW
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
    Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranuclear Delivery of HIF-1α-TMD Alleviates EAE
    Shin JS; Kim I; Moon JS; Ho CC; Choi MS; Ghosh S; Lee SK
    Front Immunol; 2021; 12():741938. PubMed ID: 34745114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (Tim-3).
    Möller-Hackbarth K; Dewitz C; Schweigert O; Trad A; Garbers C; Rose-John S; Scheller J
    J Biol Chem; 2013 Nov; 288(48):34529-44. PubMed ID: 24121505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzyme.
    Liu X; He F; Pang R; Zhao D; Qiu W; Shan K; Zhang J; Lu Y; Li Y; Wang Y
    J Biol Chem; 2014 Oct; 289(42):28971-86. PubMed ID: 25183005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2.
    Prigione A; Rohwer N; Hoffmann S; Mlody B; Drews K; Bukowiecki R; Blümlein K; Wanker EE; Ralser M; Cramer T; Adjaye J
    Stem Cells; 2014 Feb; 32(2):364-76. PubMed ID: 24123565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
    Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
    Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.
    Giacoppo S; Pollastro F; Grassi G; Bramanti P; Mazzon E
    Fitoterapia; 2017 Jan; 116():77-84. PubMed ID: 27890794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5.
    Zhang Y; Blattman JN; Kennedy NJ; Duong J; Nguyen T; Wang Y; Davis RJ; Greenberg PD; Flavell RA; Dong C
    Nature; 2004 Aug; 430(7001):793-7. PubMed ID: 15306813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.